Table 1.
Baseline characteristics
| Subjects | Intervention group (N = 44) | Control group (N = 45) | ||
|---|---|---|---|---|
| Left-sided icepacks (N = 24) | Bilateral icepacks (N = 20) | No icepacks (N = 45) | p value* | |
| Age (years) | ||||
| Mean (± SD) | 72.79 (± 4.86) | 71.00 (± 5.91) | 70.67 (± 7.57) | 0.46 |
| Range (years) | 64–81 | 62–82 | 49–91 | |
| Initial Gleason Score (N) | 24 (0 missing) | 18 (2 missing) | 41 (4 missing) | 0.17 |
| Low risk(< 7) | 9 | 9 | 8 | |
| Intermediate risk (7) | 7 | 5 | 19 | |
| High risk (> 7) | 8 | 4 | 14 | |
| PSA at scan (ng/ml) | ||||
| Mean (± SD) | 24.3 (± 35.23) | 11.79 (± 10.61) | 18.17 (± 31.68) | 0.38 |
| Range | 1.10–164.7 | 0.12–35.0 | 0.20–120.0 | |
| Scan indication (N) | 24 (0 missing) | 20 (0 missing) | 45 (0 missing) | |
| - Primary staging | 5 | 2 | 4 | |
| - Re-staging | 19 | 17 | 35 | |
| - Other indications | 0 | 1 | 6 | |
| Previous therapy regimens (N) | 24 (0 missing) | 19 (1 missing) | 45 (0 missing) | |
| - No treatment | 5 | 0 | 4 | |
| - Radical prostatectomy | 3 | 6 | 17 | |
| - Radiation therapy | 10 | 11 | 12 | |
| - Radiation therapy + hormonal therapy (Bolla [23]) | 2 | 1 | 7 | |
| - Other treatment regimens | 4 | 1 | 5 | |
| Adjuvant/salvage (radiation/hormonal) therapy regimens (N) | 24 (0 missing) | 17 (3 missing) | 44 (1 missing) | 0.34 |
| - Yes | 9 | 3 | 11 | |
| - No | 15 | 14 | 33 | |
*p < 0.05 is considered significant